A study led by Columbia obstetricians has shown that a new intrauterine device can rapidly control postpartum hemorrhage, a major cause of severe maternal morbidity and death, in real-world situations.
Court allows Axonics neurostim patent case to proceed against Medtronic
Dive Brief: A federal appeals court ruled on Monday that Axonics can continue to press claims against Medtronic in an ongoing legal dispute over neurostimulation patents